4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Metastatic tumours facilitated by hypoxic tumour micro-environments (METOXIA)
Date du début: 1 févr. 2009, Date de fin: 31 juil. 2014,
"Recent research suggests that the hypoxic micro-environment of tumours is one of the major drivers of metastatic spread of cancer. Furthermore, hypoxic tumour micro-environments may result in treatment resistance of cancer cells, therefore causing a double effect of reducing the potential of a successful treatment of the cancer patient. This project seeks to clarify the roles and functions of the ...
Voir le projet
21
Participants partenaires
TERMINÉ
Pan-European network for the study and clinical management of drug resistant tuberculosis (TB PAN-NET)
Date du début: 1 janv. 2009, Date de fin: 30 juin 2014,
"This proposal will establish an integrated and synergistic network to address the challenge of multiple drug resistant tuberculosis (MDR-TB) facing the EU. The objective will be attained through the establishment of a European consortium of expert partners with extensive experience in the conduct of basic and clinical research relating to MDR-TB, TB control and epidemiology. This Consortium will ...
Voir le projet
32
Participants partenaires
TERMINÉ
Strengthening and Sustaining the European Perspectives of Molecular Biotechnology in Lithuania (MoBiLi)
Date du début: 1 déc. 2009, Date de fin: 30 nov. 2013,
MoBiLi is a support action to strengthen the research capacities and to mobilize human resources in molecular biotechnology at the Institute of Biotechnology (IBT) Vilnius, Lithuania. Modern molecular biotechnology is a multidisciplinary research arena that integrates structural knowledge at different levels into cellular contexts to underpin biomedical questions. Such a multidisciplinary approach ...
Voir le projet
1
Participant partenaire
TERMINÉ
Small Molecule Inhibitors of the Trimeric Influenza Virus Polymerase Complex (FLUINHIBIT)
Date du début: 1 avr. 2008, Date de fin: 31 mars 2010,
"The clock is counting down to the next influenza pandemic. Since 1997, the avian influenza virus strain H5N1 has infected over 250 people worldwide with a fatality rate of ~60%, although so far without sustained human-to-human transmission. In view of the very few efficacious drugs against influenza virus infections and the time it takes to develop a matching vaccine, there is an unmet worldwide ...
Voir le projet